×
News Home

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Falls -8.80% This Week; Should You Buy?

Wednesday, January 27, 2021 01:19 PM | InvestorsObserver Analysts
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Falls -8.80% This Week; Should You Buy?

Alnylam Pharmaceuticals, Inc. (ALNY) stock has gained 35.91% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ALNY stock a score of 66 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 89. ALNY's rank also includes a long-term technical score of 86. The fundamental score for ALNY is 22. In addition to the average rating from Wall Street analysts, ALNY stock has a mean target price of 167.6. This means analysts expect the stock to climb 7.49% over the next 12 months.

Overall Score - 66
ALNY has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on ALNY!

What's Happening with ALNY Stock Today

Alnylam Pharmaceuticals, Inc. (ALNY) stock is lower by -8.29% while the S&P 500 is lower by -1.41% as of 1:01 PM on Wednesday, Jan 27. ALNY is lower by -$14.10 from the previous closing price of $170.02 on volume of 559,685 shares. Over the past year the S&P 500 has gained 15.84% while ALNY has gained 35.91%. ALNY lost -$7.83 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Alnylam Pharmaceuticals, Inc. (ALNY) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App